» Authors » Inge C Gyssens

Inge C Gyssens

Explore the profile of Inge C Gyssens including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 71
Citations 1567
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
DOnofrio V, Cartuyvels R, Messiaen P, Barisic I, Gyssens I
Microorganisms . 2023 Jul; 11(7). PMID: 37512999
Background: harbours virulence factors that facilitate the development of bloodstream infections. Studies determining virulence factors in clinical isolates often have limited access to clinical data and lack associations with patient...
2.
Peeters T, Houben B, Cools P, Thys Y, DOnofrio V, Martens S, et al.
Heliyon . 2023 May; 9(4):e15131. PMID: 37128345
Purpose: Acute appendicitis is a common abdominal emergency worldwide. This study aimed at characterizing environmental risk factors influencing the development and severity of acute appendicitis. Methods: Patients from a Belgian...
3.
Ardal C, Baraldi E, Busse R, Castro R, Ciabuschi F, Cisneros J, et al.
Lancet . 2023 Feb; 403(10422):e2-e4. PMID: 36774936
No abstract available.
4.
Ricano-Ponce I, Peeters T, Matzaraki V, Houben B, Achten R, Cools P, et al.
Front Immunol . 2022 Jun; 13:862742. PMID: 35693796
Background: Acute appendicitis is one of the most common abdominal emergencies worldwide. Both environmental and genetic factors contribute to the disease. C-reactive protein (CRP) is an important biomarker in the...
5.
DOnofrio V, Heylen D, Pusparum M, Grondman I, Vanwalleghem J, Meersman A, et al.
J Intensive Care . 2022 Mar; 10(1):13. PMID: 35264246
Background: Sepsis is a life-threatening organ dysfunction. A fast diagnosis is crucial for patient management. Proteins that are synthesized during the inflammatory response can be used as biomarkers, helping in...
6.
Franceschini E, Cozzi-Lepri A, Santoro A, Bacca E, Lancellotti G, Menozzi M, et al.
Microorganisms . 2021 Sep; 9(9). PMID: 34576791
Background: Herpes simplex 1 co-infections in patients with COVID-19 are considered relatively uncommon; some reports on re-activations in patients in intensive-care units were published. The aim of the study was...
7.
Meschiari M, Lopez-Lozano J, Di Pilato V, Gimenez-Esparza C, Vecchi E, Bacca E, et al.
Antimicrob Resist Infect Control . 2021 Aug; 10(1):123. PMID: 34412693
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) infection outbreaks are difficult to control and sometimes require cohorting of CRAB-positive patients or temporary ward closure for environmental cleaning. We aimed at controlling the...
8.
Monnier A, Tacconelli E, Ardal C, Cavaleri M, Gyssens I
JAC Antimicrob Resist . 2021 Jul; 2(2):dlaa034. PMID: 34222996
Objectives: This case study addresses: (i) antibiotic treatment options for bacteraemia (SAB), for both empirical and targeted therapy; (ii) the current status of and priorities for the antibiotic pipeline to...
9.
DOnofrio V, Meersman A, Magerman K, Waumans L, van Halem K, Cox J, et al.
Int J Antimicrob Agents . 2021 Jun; 58(3):106379. PMID: 34161787
Objectives: To perform an audit of empirical antibiotic therapy (EAT) of sepsis at the emergency department and to analyse the impact of an antimicrobial stewardship (AMS) programme on process and...
10.
DOnofrio V, Meersman A, Vijgen S, Cartuyvels R, Messiaen P, Gyssens I
Open Forum Infect Dis . 2021 Jan; 8(1):ofaa594. PMID: 33511231
Background: There is a clear need for a better assessment of independent risk factors for in-hospital mortality, intensive care unit admission, and bacteremia in patients presenting with suspected sepsis at...